Výsledky vyhľadávania - "воспроизводимость"

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Prispievatelia: Khromova S.V. Karmazanovsky G.G. Karelskaya N.A. a ďalší

    Zdroj: Almanac of Clinical Medicine; Vol 52, No 1 (2024); 25-34 ; Альманах клинической медицины; Vol 52, No 1 (2024); 25-34 ; 2587-9294 ; 2072-0505

    Popis súboru: application/pdf

  9. 9
  10. 10
  11. 11

    Zdroj: Известия Томского политехнического университета
    Bulletin of the Tomsk Polytechnic University

    Popis súboru: application/pdf

  12. 12

    Zdroj: Clinical pharmacy; Vol. 24 No. 1 (2020); 56-62
    Клиническая фармация; Том 24 № 1 (2020); 56-62
    Клінічна фармація; Том 24 № 1 (2020); 56-62
    Клінічна фармація; Том 24, № 1 (2020); 56-62
    Clinical pharmacy; Том 24, № 1 (2020); 56-62
    Клиническая фармация; Том 24, № 1 (2020); 56-62

    Popis súboru: application/pdf

  13. 13
  14. 14

    Zdroj: Science Editor and Publisher; Vol 7, No 2 (2022); 143-165 ; Научный редактор и издатель; Vol 7, No 2 (2022); 143-165 ; 2541-8122 ; 2542-0267

    Popis súboru: application/pdf

    Relation: https://www.scieditor.ru/jour/article/view/302/195; Hrynaszkiewicz I. Publishers’ responsibilities in promoting data quality and reproducibility. In: Bespalov A., Michel M., Steckler T. (eds) Good research practice in non-clinical pharmacology and biomedicine. Handbook of experimental pharmacology. Springer, Cham; 2019. Vol. 257, pp. 319–348. https://doi.org/10.1007/164_2019_290; Baker M. 1,500 scientists lift the lid on reproducibility. Nature. 2016;533:452–454. https://doi.org/10.1038/533452a; Lane T. Creating a culture of publication integrity together [Presentation]. In: COPE Forum on good publication practices, University of Macau, Dec. 2, 2022. URL: https://publicationethics.org/sites/default/files/culturepublication-integrity-macau.pdf (accessed 10.12.2022).; John L.K., Loewenstein G., Prelec D. Measuring the prevalence of questionable research practices with incentives for truth telling. Psychological Science. 2012;23(5):524–532. https://doi.org/10.1177/0956797611430953; Fanelli D. How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data. PLoS ONE. 2009;4(5):e5738. https://doi.org/10.1371/journal.pone.0005738; Berman F., Crosas M. The research data alliance: Benefits and challenges of building a community organization. Harvard Data Science Review. 2020;2(1). https://doi.org/10.1162/99608f92.5e126552; Hofman J.M., Goldstein D.G., Sen S., Poursabzi-Sangdeh F., Allen J., Dong L.L. et al. Expanding the scope of reproducibility research through data analysis replications. Organizational Behavior and Human Decision Processes. 2021;164:192–202. https://doi.org/10.1016/j.obhdp.2020.11.003; Targowski P., Iwanicka M., Sylwestrzak M., Frosinini C., Striova J., Fontana R. Using optical coherence tomography to reveal the hidden history of The Landsdowne Virgin of the Yarnwinder by Leonardo da Vinci and studio. Angewandte Chemie International Edition. 2018;57(25):7396–7400. https://doi.org/10.1002/anie.201713356; Taichman D.B., Sahni P., Pinborg A., Peiperl L., Laine C., James A. et al. Data sharing statements for clinical trials: A requirement of the international committee of medical journal editors. JAMA. 2017;317(24):2491–2492. https://doi.org/10.1001/jama.2017.6514; Bergeat D., Lombard N., Gasmi A., Le Floch B., Naudet F. Data sharing and reanalyses among randomized clinical trials published in surgical journals before and after adoption of a data availability and reproducibility policy. JAMA Netw Open. 2022;5(6):e2215209. https://doi.org/10.1001/jamanetworkopen.2022.15209; Fraggetta F., Yagi Y., Garcia-Rojo M., Evans A.J., Tuthill J.M., Baidoshvili A. et al. The importance of eSlide Macro images for primary diagnosis with whole slide imaging. Journal of Pathology Informatics. 2018;9(1):46. https://doi.org/10.4103/jpi.jpi_70_18; Stuart D., Baynes G., Hrynaszkiewicz I., Allin K., Penny D., Lucraft M., et al. Whitepaper: Practical challenges for researchers in data sharing figshare. Journal Contribution. 2018; 21 Mar. https://doi.org/10.6084/m9.figshare.5975011.v1; Hansson K., Dahlgren A. Open research data repositories: Practices, norms, and metadata for sharing images. Journal of the Association for Information Science and Technology. 2021;73(2):303–316. https://doi.org/10.1002/asi.24571; Fennell C., Cousijn H. Supporting data openness, transparency & sharing: Elsevier signs up to TOP guidelines & develops new data-sharing guidelines for journals. Elsevier Connect, Sept. 4, 2017. URL: https://www.elsevier.com/connect/editors-update/supporting-openness,-transparency-and-sharing (accessed 10.12.2022).; Witt M., Weisweiler N., Ulrich R. Happy 10th Anniversary, re3data! DataCite Blog, Aug. 30, 2022. https://doi.org/10.5438/mqw0-yt07; Soderberg C.K. Using OSF to share data: A step-by-step guide. Practices in Psychological Science. 2018;1(1):115–120. https://doi.org/10.1177/2515245918757689; Christensen G., Dafoe A., Miguel E., Moore D.A., Rose A. K. A study of the impact of data sharing on article citations using journal policies as a natural experiment. PLoS ONE. 2019;14(12):e0225883. https://doi.org/10.1371/journal.pone.0225883; McGillivray B., Marongiu P., Pedrazzini N., Ribary M., Wigdorowitz M., Zordan E. Deep impact: A study on the impact of data papers and datasets in the humanities and social sciences. Publications. 2022;10(4):39. https://doi.org/10.3390/publications10040039; Colavizza G., Hrynaszkiewicz I., Staden I., Whitaker K., McGillivray B. The citation advantage of linking publications to research data. PLoS ONE. 2020;15(4): e0230416. https://doi.org/10.1371/journal.pone.0230416; Dorch S. B. F., Drachen T.M., Ellegaard O. The data sharing advantage in astrophysics. arXiv:1511.02512. https://doi.org/10.48550/arXiv.1511.02512; Henneken E.A., Accomazzi A. Linking to Data – Effect on Citation Rates in Astronomy. arXiv:1111.3618. https://doi.org/10.48550/arXiv.1111.3618; Sears J. Data sharing effect on article citation rate in paleoceanography. Figshare. Dataset. Oct. 31, 2014. https://doi.org/10.6084/m9.figshare.1222998.v1; Piwowar H.A., Vision T.J. Data reuse and the open data citation advantage. PeerJ. 2013;1(3):e175. https://doi.org/10.7717/peerj.175; Vasilevsky N.A., Minnier J., Haendel M.A., Champieux R.E. Reproducible and reusable research: Are journal data sharing policies meeting the mark? PeerJ. 2017;5:e3208. https://doi.org/10.7717/peerj.3208; Smith G. How sharing your data could increase your citations. Springer Nature, June 8, 2021. URL: https://researchdata.springernature.com/posts/how-sharing-your-data-could-increase-your-citations (accessed 10.12.2022).; Мжельский А.А., Москалева О.В. Научная кооперация как фактор, влияющий на цитируемость статьи. Аналитический обзор. Управление наукой: теория и практика. 2020;2(3):138–164. https://doi.org/10.19181/smtp.2020.2.3.8; Nosek B.A., Alter G., Banks G.C., Borsboom D., Bowman S.D., Breckler S. J. et al. Promoting an open research culture: Author guidelines for journals could help to promote transparency, openness, and reproducibility. Science. 2015;348(6242):1422–1425. https://doi.org/10.1126/science.aab2374; Nundy S., Kakar A., Bhutta Z. A. How to write the material (patients) and methods section. In: How to practice academic medicine and publish from developing countries? Singapore: Springer; 2022, pp. 213–217. https://doi.org/10.1007/978-981-16-5248-6_19; Announcement: Where are the data? Nature. 2016;537:138. https://doi.org/10.1038/537138a; Chen Y., Yang K., Marušić A., Qaseem A., Meerpohl J. J., Flottorp S. et al. A reporting tool for practice guidelines in health care: The RIGHT statement. Annals of Internal Medicine. 2017;166:128–132. https://doi.org/10.7326/M16-1565; Belletti A., Todaro G., Valsecchi G., Losiggio R., Palumbo D., Landoni G., Zangrillo A. Barotrauma in coronavirus disease 2019 patients undergoing invasive mechanical ventilation: A systematic literature review. Critical Care Medicine. 2022;50(3):491–500. https://doi.org/10.1097/CCM.0000000000005283; Huang J., Deng Y., Tin M. S., Lok V., Ngai C. H., Zhang L. et al. Distribution, risk factors, and temporal trends for lung cancer incidence and mortality: A global analysis. Thoracic Oncology. 2022;161(4):1101–1111. https://doi.org/10.1016/j.chest.2021.12.655; Gerrits R.G., Jansen T., Mulyanto J., van den Berg M.J., Klazinga N.S., Kringos D.S. Occurrence and nature of questionable research practices in the reporting of messages and conclusions in international scientific Health Services Research publications: a structured assessment of publications authored by researchers in the Netherlands. BMJ Open. 2019;9:e027903. https://doi.org/10.1136/bmjopen-2018-027903; Vedantam S. Journals insist drug manufacturers register all trials. Washington Post, Sept. 9, 2004. URL: https://www.washingtonpost.com/archive/politics/2004/09/09/journals-insist-drug-manufacturers-register-alltrials/37be9ce1-23fd-4b07-943c-73336c5375a1/ (accessed 10.12.2022).; Smulders Y.M. A two-step manuscript submission process can reduce publication bias. Journal of Clinical Epidemiology. 2013;66(9):946–947. https://doi.org/10.1016/j.jclinepi.2013.03.023; Soderberg C.K., Errington T.M., Schiavone S.R., Bottesini J., Thorn F.S., Vazire S. et al. Initial evidence of research quality of registered reports compared with the standard publishing model. Nature Human Behaviour. 2021;5:990–997. https://doi.org/10.1038/s41562-021-01142-4; McNutt M.K., Bradford M., Drazen J.M., Hanson B., Howard B., Jamieson K.H., et al. Transparency in authors’ contributions and responsibilities to promote integrity in scientific publication. PNAS. 2018;115(11):2557–2560. https://doi.org/10.1073/pnas.1715374115; Adams J., Pendlebury D., Potter R., Szomszor M. Global Research Report: Multi-authorship and research analytics. Clarivate Analytics, ISI, Web of Science Group; 2019. 20 p. URL: https://clarivate.com/wp-content/uploads/2021/02/ISI_-Multiauthorship_Global_Research_Report.pdf (accessed 10.12.2022).; Заболотских И.Б., Трембач Н.В., Мусаева Т.С., Дунц П.В., Голубцов В.В., Григорьев Е.В. и др. Национальное многоцентровое проспективное обсервационное исследование «Роль сопутствующих заболеваний в стратификации риска послеоперационных осложнений» – STOPRISK: протокол исследования. Вестник интенсивной терапии имени А. И. Салтанова. 2022;(4):24–35. https://doi.org/10.21320/1818-474X-2022-4-24-35; Заболотских И.Б., Мжельский А.А. Что стоит за различными показателями роста [видео]. Пленарное заседание Всероссийской научно-образовательной конференции, посвященной 30-летнему юбилею журнала «Вестник интенсивной терапии имена А.И. Салтанова, 18–19 нояб. 2022 г. URL: https://www.youtube.com/watch?v=O26-VyOiaZI (дата обращения: 12.12.2022).; Bird A. Understanding the Replication Crisis as a Base Rate Fallacy. The British Journal for the Philosophy of Science. 2021;72(4):965–993. https://doi.org/10.1093/bjps/axy051; https://www.scieditor.ru/jour/article/view/302

  15. 15
  16. 16

    Zdroj: Clinical pharmacy; Vol. 23 No. 3 (2019); 12-18
    Клиническая фармация; Том 23 № 3 (2019); 12-18
    Клінічна фармація; Том 23 № 3 (2019); 12-18
    Klìnìčna farmacìâ; Том 23, № 3 (2019); 12-18
    Клиническая фармация; Том 23, № 3 (2019); 12-18
    Клінічна фармація; Том 23, № 3 (2019); 12-18

    Popis súboru: application/pdf

  17. 17
  18. 18

    Prispievatelia: M. A. Burakova O. N. Abrosimova Yu. M. Ladutko a ďalší

    Zdroj: Drug development & registration; Том 11, № 1 (2022); 59-67 ; Разработка и регистрация лекарственных средств; Том 11, № 1 (2022); 59-67 ; 2658-5049 ; 2305-2066

    Popis súboru: application/pdf

    Relation: https://www.pharmjournal.ru/jour/article/view/1162/946; https://www.pharmjournal.ru/jour/article/downloadSuppFile/1162/1036; Анализ российского рынка парфюмерии и косметики. Доступно по: http://www.lawlinks.ru/view_obzors.php?id=4768. Ссылка активна на 10.06.2021.; Производство эмульсионных кремов. Доступно по: http://www.lisyz.ru/tehnologii-proizvodstva/proizvodstvoemulsionnyh-kremov.html. Ссылка активна на 10.06.2021.; Cizauskaite U., Marksa M., Bernatoniene J. The optimization of technological processes, stability and microbiological evaluation of innovative natural ingredients based multiple emulsion. Pharmaceutical Development and Technology. 2018;23:636–645. DOI:10.1080/10837450.2017.1350981.; ТР ТС 009/2011 Технический регламент Таможенного союза «О безопасности парфюмерно-косметической продукции». Доступно по: http://docs.cntd.ru/document/902303206. Ссылка активна на 10.06.2021.; Косметические эмульсии: какие проблемы возникают при разработке и производстве. Доступно по: https://www.korolevpharm.ru/articles/kosmeticheskie-emulsii-kakie-problemyvoznikayut-pri-razrabotke-i-proizvodstve.html. Ссылка активна на 10.06.2021.; EMA/CHMP/CVMP/QWP/BWP/70278/2012-Rev 1 Guideline on process validation for finished products – information and data to be provided in regulatory submissions. Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/guidelineprocess-validation-finished-products-information-data-beprovided-regulatory-submissions_en.pdf. Accessed: 10.06.2021.; Рожнова С. А., Цыпкина А. В. Анализ системы организации фармацевтической разработки лекарственных средств. Разработка и регистрация лекарственных средств. 2017;(3):170–176.; Смехова И. Е., Шигарова Л. В., Наркевич И. А., Флисюк Е. В., Метелева В. Д. Документирование фармацевтической разработки. Часть 2. Документы системы качества. Разработка и регистрация лекарственных средств. 2021;10(2):147–153. DOI:10.33380/2305-2066-2021-10-2-147-153; Reamer A. Icerman L. and Youtie J. Technology Transfer and Commercialization: Their Role in Economic Development. An overview for pharmaceutical industry. 2010:1-10.; Singh Manral M., Prasharl B., Sheikh Ya. Technology Transfer in Pharmaceutical Industry; Facts and Steps Involved. American Journal of PharmTech Research. 2012;2(4):74–82.; EMA/CHMP/QWP/BWP/245074/2015 Guideline on manufacture of the finished dosage form. 4 July 2017. Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/guidelinemanufacture-finished-dosage-form-revision-1_en.pdf. Accessed: 10.06.2021.; John R. M. Technology transfer in pharmaceutical industry. The Pharma Innovation Journal. 2017;6(3):235–240.; Waghmare Y. S., Mahaparale S. P. The important role of technology transfer in pharmaceutical industry-a review. World Journal of Pharmaceutics Research. 2017;6(9):310–329.; Mohite P. B., Sangle S. V. Technology transfer in pharmaceutical industry-a review. International Journal of Advances in Pharmaceutics Research. 2017;6:1–7.; Pavithra G. M., Manoranjith, S. Nagalakshmi. An overview of technology transfer as a regulatory aspect. International Journal of Applied Pharmaceutics. 2021;13(2):14–19. DOI:10.22159/ijap.2021v13i2.40067.; Ляпунов Н. А., Безуглая Е. П., Ляпунов А. Н., Зинченко И. А., Брылёва Е. Ю., Лысокобылка А. А. Лабораторное оборудование на этапе фармацевтической разработки мягких лекарственных средств. Разработка и регистрация лекарственных средств. 2019;8(1):29–36. DOI:10.33380/2305-2066-2019-8-1-29-36.; Рудько А. И., Коников Д. Л., Сидоров К. О., Ильинова Ю. Г. Ставка на трансфер: развитие регуляторной базы для развития фармацевтической промышленности. Фармация. 2020;69(7):5–9. DOI:10.29296/25419218-2020-07-01.; Власенко Ю. В. Проектно-ориентированный подход к разработке готовых лекарственных средств на примере дженерикового многокомпонентного препарата, содержащего амоксициллин и клавулановую кислоту. Разработка и регистрация лекарственных средств. 2016;(1):30–36.; ГОСТ 29188.2-2014. Продукция парфюмерно-косметическая. Метод определения водородного показателя рН. Доступно по: https://docs.cntd.ru/document/1200136164. Ссылка активна на 10.06.2021.; ГОСТ 29188.3-91. Изделия косметические. Методы определения стабильности эмульсии. Доступно по: http://docs.cntd.ru/document/1200022370. Ссылка активна на 10.06.2021.; ГОСТ 29188.0-14. Продукция парфюмерно-косметическая. Правила приемки, отбор проб, методы органолептических испытаний. Доступно по: https://docs.cntd.ru/document/1200136165. Ссылка активна на 10.06.2021.; Государственная фармакопея. XIV издания. Доступно по: https://minzdrav.gov.ru/poleznye-resursy/xiv-izdanie-gosudarstvennoyfarmakopei-rossiyskoy-federatsii. Ссылка активна на 10.06.2021.; Strus O., Polovko N., Yezerska O. Justification of technological parameters of the cream production with sapropel extract. Pharmacia. 2019;66(1):19–25. DOI:10.3897/pharmacia.66.e35022.; Strus O., Polovko N., Plaskonis Y. The investigation of the development of a cream composition with the sapropel extract. Asian Journal of Pharmaceutical and Clinical Research. 2018;11(7):147–150. DOI:10.22159/ajpcr.2018.v11i7.23575.; Резцов Е., Могилюк В., Рябко Д. Трансфер технологий в фармацевтической отрасли. Контрактное производство и услуги. 2010;2:49–52.; Береговых В. В., Спицкий О. Р. Перенос технологий при создании производства лекарственного средства. Вестник Российской академии медицинских наук. 2013;12:49–57.; Technology Transfer. Good Practice Guide. ISPE. 2003. Available at: https://www.who.int/medicines/areas/quality_safety/quality_assurance/TransferTechnologyPharmaceuticalManufacturingTRS961Annex7.pdf. Accessed: 10.06.2021.; https://www.pharmjournal.ru/jour/article/view/1162

  19. 19

    Zdroj: Ophthalmology in Russia; Том 19, № 4 (2022); 705-718 ; Офтальмология; Том 19, № 4 (2022); 705-718 ; 2500-0845 ; 1816-5095 ; 10.18008/1816-5095-2022-4

    Popis súboru: application/pdf

    Relation: https://www.ophthalmojournal.com/opht/article/view/1973/1034; Wu H., de Boer J.F., Chen T.C. Reproducibility of retinal nerve fiber layer thickness measurements using spectral domain optical coherence tomography. J Glaucoma. 2011 Oct;20(8):470–476. DOI:10.1097/IJG.0b013e3181f3eb64; Jaffe G.J., Caprioli J. Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol. 2004 Jan;137(1):156–169. DOI:10.1016/s0002-9394(03)00792-x; Greenfield D.S., Weinreb R.N. Role of optic nerve imaging in glaucoma clinical practice and clinical trials. Am J Ophthalmol. 2008 Apr;145(4):598–603. DOI:10.1016/j.ajo.2007.12.018; Hong S., Kim C.Y., Lee W.S., Seong G.J. Reproducibility of peripapillary retinal nerve fiber layer thickness with spectral domain cirrus high definition optical coherence tomography in normal eyes. Jpn J Ophthalmol. 2010 Jan;54(1):43–47. DOI:10.1007/s10384-009-0762-8; Wojtkowski M., Srinivasan V., Fujimoto J.G., Ko T., Schuman J.S., Kowalczyk A., Duker J.S. Three dimensional retinal imaging with high speed ultrahigh resolution optical coherence tomography. Ophthalmology. 2005 Oct;112(10):1734–1746. DOI:10.1016/j.ophtha.2005.05.023; Serberac N., Beutelspacher S.C., Aboul Enein F.C. Reproducibility of highresolution OCT measurements of the nerve fiber layer with the new Heidelberg Spectralis OCT. Br J Ophthalmol June 1,2011 95:804–810. DOI:10.1136/bjo.2010.186221; Adhi M., Aziz S., Muhammad K., Adhi M.I. Macular thickness by age and gender in healthy eyes using spectral domain optical coherence tomography. PLoS One. 2012;7(5):e37638. DOI:10.1371/journal.pone.0037638; Z136 Committee. American national standard for safe use of lasers: ANSI Z136.1 2000. New York: Laser Institute of America: 2007.; Sull A.C., Vuong L.N., Price L.L., Srinivasan V.J., Gorczynska I., Fujimoto J.G. Comparison of spectral/Fourier domain optical coherence tomography instruments for assessment of normal macular thickness. Retina. 2010 Feb;30(2):235–245. DOI:10.1097/IAE.0b013e3181bd2c3b; Chan A., Duker J.S., Ko T.H., Fujimoto J.G., Schuman J.S. Normal macular thick ness measurements in healthy eyes using Stratus optical coherence tomography. Arch Ophthalmol. 2006 Feb;124(2):193–198. DOI:10.1001/archopht.124.2.193; Grover S., Murthy R.K., Brar V.S., Chalam K.V. Normative data for macular thick ness by high definition spectral domain optical coherence tomography (spectralis). Am J Ophthalmol. 2009 Aug;148(2):266–271. DOI:10.1016/j.ajo.2009.03.006; Kashani A.H., Zimmer Galler I.E., Shah S.M., Dustin L., Do D.V., Eliott D. Retinal thickness analysis by race, gender, and age using Stratus OCT. Am J Ophthalmol. 2010 Mar;149(3):496–502.e1. DOI:10.1016/j.ajo.2009.09.025; Song W.K., Lee S.C., Lee E.S., Kim C.Y., Kim S.S. Macular thickness variations with sex, age, and axial length in healthy subjects: a spectral domain optical coherence tomography study. Invest Ophthalmol Vis Sci. 2010 Aug;51(8):3913–3918. DOI:10.1167/iovs.09-4189; Duan X.R., Liang Y.B., Friedman D.S., Sun L.P., Wei W.B., Wang J.J. Prevalence and associations of epiretinal membranes in a rural Chinese adult population: the Handan Eye Study. Invest Ophthalmol Vis Sci. 2009 May;50(5):2018–2023. DOI:10.1167/iovs.08-2624; Legarreta J.E., Gregori G., Punjabi O.S., Knighton R.W., Lalwani G.A., Puliafito C.A. Macular thickness measurements in normal eyes using spectral domain optical coherence tomography. Ophthalmic Surg Lasers Imaging. 2008 Jul–Aug;39(4 Suppl):S43–49. DOI:10.3928/15428877-20080715-02; Leung C.K., Cheung C.Y., Weinreb R.N., Lee G., Lin D., Pang C.P. Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4893–4897. DOI:10.1167/iovs.07-1326; Giani A., Cigada M., Choudhry N., Deiro A.P., Oldani M., Pellegrini M. Reproducibility of retinal thickness measurements on normal and pathologic eyes by different optical coherence tomography instruments. Am J Ophthalmol. 2010 Dec;150(6):815–824. DOI:10.1016/j.ajo.2010.06.025; https://www.ophthalmojournal.com/opht/article/view/1973

  20. 20